Switching to Brimonidine/Ripasudil Fixed Combination from Brimonidine + Ripasudil

Switching to Brimonidine/Ripasudil Fixed Combination from Brimonidine + Ripasudil

Kenji Inoue,1 Minako Shiokawa,1 Shiho Kunimatsu-Sanuki,2 Goji Tomita,1,3 Kyoko Ishida3 1Inouye Eye Hospital, Tokyo, Japan; 2Nishikasai Inouye Eye Hospital, Tokyo, Japan; 3Department of Ophthalmology, Toho University Ohashi Medical Center, Tokyo, JapanCorrespondence: Kenji Inoue, Inouye Eye Hospital,...

Full description

Bibliographic Details
Main Authors:	Inoue K, Shiokawa M, Kunimatsu-Sanuki S, Tomita G, Ishida K
Format:	Article
Language:	English
Published:	Dove Medical Press 2024-02-01
Series:	Clinical Ophthalmology
Subjects:	adverse reactions brimonidine/ripasudil intraocular pressure fixed combination switching usability
Online Access:	https://www.dovepress.com/switching-to-brimonidineripasudil-fixed-combination-from-brimonidine---peer-reviewed-fulltext-article-OPTH

Similar Items

Evaluation of the Use of Brinzolamide-Brimonidine Fixed Combination in Maximum Medical Therapy
by: Oya Tekeli, et al.
Published: (2022-08-01)

Role of ripasudil as an adjunct treatment in the management of pseudoexfoliative glaucoma
by: Sumita Mohapatra, et al.
Published: (2023-01-01)

Brinzolamide/Brimonidine Fixed Combination: Simplifying Glaucoma Treatment Regimens
by: Reza Moosavi, et al.
Published: (2018-10-01)

Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
by: Wang N, et al.
Published: (2020-01-01)

Efficacy and safety of various brimonidine formulations in the treatment of glaucoma and ocular hypertension
by: A. V. Sidorova, et al.
Published: (2021-07-01)

Intraocular pressure-lowering effects of Ripasudil: a potential outcome marker for Trabeculotomy
by: Erina Goda, et al.
Published: (2019-12-01)

Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes
by: Thomas Ravi, et al.
Published: (2003-01-01)

Maximum Medical Therapy: Brinzolamide/Brimonidine And Travoprost/Timolol Fixed-Dose Combinations In Glaucoma And Ocular Hypertension
by: Lerner SF, et al.
Published: (2019-12-01)

Switching from concomitant therapy to tafluprost/timolol fixed combination
by: Inoue K, et al.
Published: (2018-03-01)

Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study
by: Yusuke Orii, et al.
Published: (2023-06-01)

The Efficacy, Safety, and Satisfaction Associated with Switching from Brinzolamide or Brimonidine to Brinzolamide/Brimonidine in Open-Angle Glaucoma Patients
by: Hiromitsu Onoe, et al.
Published: (2022-12-01)

Effect of a fixed combination of ripasudil and brimonidine on aqueous humor dynamics in mice
by: Reiko Yamagishi-Kimura, et al.
Published: (2024-04-01)

Neuroprotective properties of Brimonidine
by: Т. N. Mikhailova
Published: (2019-11-01)

Circadian Fluctuation Changes in Intraocular Pressure Measured Using a Contact Lens Sensor in Patients with Glaucoma after the Adjunctive Administration of Ripasudil: A Prospective Study
by: Shih-Kung Huang, et al.
Published: (2023-05-01)

The Efficacy, Safety and Satisfaction Associated with Switching from Brinzolamide 1% and Brimonidine 0.1% to a Fixed Combination of Brinzolamide 1% and Brimonidine 0.1% in Glaucoma Patients
by: Hiromitsu Onoe, et al.
Published: (2021-11-01)

Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination
by: Contreras-Salinas H, et al.
Published: (2021-02-01)

Comparative study of brimonidine and timolol in treatment of glaucoma
by: Jagadish Chandrarao Narasaiah Lakkineni
Published: (2015-01-01)

Active Pharmacovigilance in Peruvian Population: Surveillance of a Timolol/Brimonidine/Dorzolamide Ophthalmic Fixed Combination [Erratum]
by: Contreras-Salinas H, et al.
Published: (2022-02-01)

Ocular and Systemic Pharmacokinetics of Brimonidine and Timolol After Topical Administration in Rabbits: Comparison Between Fixed-Combination and Single Drugs
by: Gen Suzuki, et al.
Published: (2020-01-01)

Effects of 0.4% ripasudil hydrochloride hydrate on morphological changes in rabbit eyes
by: Bundit Limratchatamorn, et al.
Published: (2019-10-01)

Difference in vasoconstrictors: oxymetazoline vs. brimonidine
by: Nwanneka Okwundu, et al.
Published: (2021-02-01)

About the pathways to deliver brimonidine to the Muller’s muscle
by: Soha Ghanian, MD, et al.
Published: (2023-03-01)

Brimonidine-associated uveitis – a descriptive case series
by: Susanne Hopf, et al.
Published: (2020-12-01)

Brimonidine as a possible treatment for myopia
by: Zixuan Peng, et al.
Published: (2024-04-01)

Effectiveness of Netarsudil versus Brimonidine in Eyes already Being Treated with Glaucoma Medications at a Single Academic Tertiary Care Practice: A Comparative Study
by: Alex T. Pham, BS, et al.
Published: (2023-01-01)

The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations
by: Ruiz Simonato Alonso, et al.
Published: (2020-03-01)

Stratification-Based Investigation of Adjunctive Brimonidine or Timolol to a Prostaglandin Analogue in Japanese Patients with Normal-Tension Glaucoma
by: Yoshikawa K, et al.
Published: (2021-07-01)

Frequency of Use of Fixed-Combination Eye Drops by Patients with Glaucoma at Multiple Private Practices in Japan
by: Inoue K, et al.
Published: (2022-03-01)

Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability
by: Anderson MS, et al.
Published: (2017-07-01)

The effect of single dose of brimonidine-purite 0.15% on choroidal thickness in healthy volunteers
by: Suleyman Demircan, et al.
Published: (2017-11-01)

Nummular keratitis: A rare manifestation of brimonidine allergy
by: Maitha Al Asmi, et al.
Published: (2024-01-01)

Effect of brimonidine tartrate on basophil activation in glaucoma patients
by: Eldar Rosenfeld, et al.
Published: (2020-03-01)

Topical brimonidine for pyogenic granuloma after paronychia surgery
by: Yusha Chen, MM, et al.
Published: (2021-01-01)

Effects of Ripasudil on Open-Angle Glaucoma after Circumferential Suture Trabeculotomy Ab Interno
by: Tomoki Sato, et al.
Published: (2021-01-01)

Safety and Efficacy of the Rho-Kinase Inhibitor (Ripasudil) in Bleb Needling after Trabeculectomy: A Prospective Multicenter Study
by: Yu Mizuno, et al.
Published: (2023-12-01)

A multicenter phase II study on the safety of rho-kinase inhibitor (ripasudil) with needling for the patients after trabeculectomy
by: Yu Mizuno, et al.
Published: (2023-06-01)

Brimonidine is Neuroprotective in Animal Paradigm of Retinal Ganglion Cell Damage
by: Federica Conti, et al.
Published: (2021-07-01)

Brimonidine Eye Drops within the Reach of Children: A Possible Foe
by: Daniela Trotta, et al.
Published: (2024-03-01)

Efficacy of three different formulations of brimonidine for control of intraocular pressure in primary open-angle glaucoma: A 6-week randomized trial
by: Anubha Bhatti, et al.
Published: (2018-01-01)

Preparation and Characterization of Ion-Sensitive Brimonidine Tartrate In Situ Gel for Ocular Delivery
by: Haonan Xu, et al.
Published: (2023-01-01)